RREVU — RRE Ventures Acquisition Corp.
—
Nasdaq ·
Financials ·
Diversified Financial Services ·
CIK 2123969 ·
Last close
$10.07
Market Cap
—
52W High
$10.50
52W Low
$9.96
ADV30
280
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | 456,407 | — | 491,418 |
| Feb 2026 | — | — | — | — | 311,274 | — | 312,402 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-60,011
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HASI | HA Sustainable Infrastructure Capital, Inc. | $4.60B | $35.82 | — |
| DMII | Drugs Made In America Acquisition II Corp. | $648.47M | $10.18 | — |
| EVAC | EQV Ventures Acquisition Corp. II | $484.50M | $10.32 | — |
| BCSS | Bain Capital GSS Investment Corp. | $483.07M | $10.30 | — |
| CEPF | Cantor Equity Partners IV, Inc. | $472.77M | $10.30 | — |
Recent Insider Activity
No insider activity indexed for this ticker.